Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Peter Richmond(University of Western Australia), Lara Hatchuel(Linear Clinical Research), Min Dong(Clover Biopharmaceuticals (China)), Brenda Ma(Clover Biopharmaceuticals (China)), Branda Hu(Clover Biopharmaceuticals (China)), Igor Smolenov(Clover Biopharmaceuticals (China)), Ping Li(Clover Biopharmaceuticals (China)), Peng Liang(Clover Biopharmaceuticals (China)), Htay Htay Han(Clover Biopharmaceuticals (China)), Joshua G. Liang(Clover Biopharmaceuticals (China)), Ralf Clemens
Cited by 281Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis